Abbas Mirshafiey
机构: Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
每年引用次数
引用次数
引用: 7,324
H-指数: 48
I10-指数 : 164
出版物: 299
Opportunistic fungal infections in patients with HIV and AIDS.
A. Mirshafiey , D. Haghmorad , M. Moazeni
Journal of Chinese Clinical Medicine 4 ( 2) 106 -120
2
2009
Immune response in histoplasmosis.
A. Mirshafiey , N. Darabi
Journal of Chinese Clinical Medicine 5 ( 2) 100 -110
2010
Immune mechanisms in coccidioidomycosis.
A. Mirshafiey , Z. Jahanshiri
Journal of Chinese Clinical Medicine 4 ( 9) 520 -533
1
2009
Opioids and opioid receptors in multiple sclerosis.
A. Mirshafiey , M. Mohsenzadegan
Journal of Chinese Clinical Medicine 5 ( 3) 171 -177
2010
The Effects of Vitamins E and D Supplementation on Erythrocyte Superoxide Dismutase and Catalase in Atopic Dermatitis
A. Mirshafiey , M. Djalali , M. R. Eshraghian , F. Siassi
Iranian Journal of Public Health 39 ( 1) 57 -63
14
2010
The effect of isosorbide on gelatinase-A and gelatinase-B activity in leukemic cell lines
F. Hajighasmi , A. Mirshafiey
Scientific Journal of Iran Blood Transfus Organ 12 ( 1) 46 -54
2015
Dendritic cell and Cryptococcus neoformans.
A. Mirshafiey , A. Amari
Journal of Chinese Clinical Medicine 4 ( 11) 641 -651
2009
Superoxide dismutase: a light horizon in treatment of multiple sclerosis.
A. Mirshafiey , S. Namaki , M. Mohsenzadegan
Journal of Chinese Clinical Medicine 4 ( 10) 585 -591
5
2009
Immunomodulatory and Immunosuppressive Roles of 1α,25(OH)2D3 in Autoimmune Diseases.
H. Alhassan Mohammed , A. A. Saboor-Yaraghi , A. Mirshafiey , H. Vahedi
Scandinavian Journal of Immunology 85 ( 2) 95 -103
24
2017
Frequency and Expression of Inhibitory Markers of CD4+CD25+FOXP3+ Regulatory T Cells in Patients with Common Variable Immunodeficiency
N. Arandi , A. Mirshafiey , H. Abolhassani , M. Jeddi-Tehrani
Scandinavian Journal of Immunology 77 ( 5) 405 -412
32
2013
Immunoregulation of Inflammatory and Inhibitory Cytokines by Vitamin D3 in Patients with Inflammatory Bowel Diseases.
H. Alhassan Mohammed , A. Mirshafiey , H. Vahedi , G. Hemmasi
Scandinavian Journal of Immunology 85 ( 6) 386 -394
16
2017
M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway.
S. Aletaha , L. Haddad , M. Roozbehkia , R. Bigdeli
Scandinavian Journal of Immunology 85 ( 2) 122 -129
19
2017
Production of M2000 (β-d-mannuronic acid) and its therapeutic effect on experimental nephritis
A. Mirshafiey , B. Rehm , R. Safari Abhari , Z. Borzooy
Environmental Toxicology and Pharmacology 24 ( 1) 60 -66
30
2007
M2000, Foundation of a New Generation Among NSAIDs
A. Mirshafiey , B. Rehm , S. Cuzzocrea , H. Matsuo
Letters in Drug Design & Discovery 2 ( 5) 412 -423
1
2005
Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
F. Jadidi-Niaragh , A. Mirshafiey
Scandinavian Journal of Immunology 74 ( 1) 1 -13
282
2011
The Role of Natural Killer Cells in Alzheimer’s Disease
F. Jadidi-Niaragh , H. Shegarfi , F. Naddafi , A. Mirshafiey
Scandinavian Journal of Immunology 76 ( 5) 451 -456
27
2012
Therapeutic approach by Aloe vera in experimental model of multiple sclerosis.
A. Mirshafiey , B. Aghily , S. Namaki , A. Razavi
Immunopharmacology and Immunotoxicology 32 ( 3) 410 -415
12
2010
Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients.
N.A.G. Gaafar , M. Aslani , Z. Aghazadeh , S.S. Mortazavi-Jahromi
Reumatismo 72 ( 2) 93 -102
2020
Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency.
G. Azizi , H. Abolhassani , F. Kiaee , N. Tavakolinia
Allergologia Et Immunopathologia 46 ( 2) 127 -135
14
2018
Tolerability and Anti‐Inflammatory Effects of Glucuronoxylomannan in Collagen‐Induced Arthritis
A. Mirshafiey , D. T. Ngoc Dzung , J. W. Murphy , M. R. Khorramizadeh
Scandinavian Journal of Immunology 60 ( 3) 226 -232
8
2004